News

Study Confirms 4Kscore Accurately Predicts High-Grade Prostate Cancer

A blood test called the 4Kscore results in accurate detection of high-grade prostate cancer. In a prospective study of 1,012 men, this test more accurately predicted the presence of high-grade disease compared with a commonly used risk calculator in men with elevated prostate-specific antigen (PSA) levels. The results from this study (Abstract 1) were presented […]

News

OPKO’s 4Kscore Prostate Biopsy Alternative Might Reduce Unnecessary Biopsies

ORLANDO—The 4Kscore, an algorithmic analysis of data from a blood test that combines four kallikrein assays with clinical information to identify the probability of high-grade prostate tumors, could dramatically reduce the number of unnecessary prostate biopsies, according to a multi-institutional prospective study (Abstract 1) presented during the 2015 Genitourinary Cancers Symposium.1 “The 4Kscore demonstrated excellent […]

News

OPKO Health CEO Dr. Frost Discusses BioReference Labs Acquisition, Impact of 4Kscore Test with Jim Cramer on Mad Money

OPKO Health CEO Dr. Phillip Frost visited Jim Cramer on Mad Money September 25, 2015, to explain the recent acquisition of Bio-Reference Laboratories and the impact it expects to have on our overall business. As Dr. Frost explained: “This is probably the best, and most interesting acquisition I have ever made.  First of all we realized […]